Skip to content

Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3-PRIMULTI trial.

Sep 2026 · European heart journal. Acute cardiovascular care · 0 citations
Medicine

TL;DR

In patients aged ≥75 years, clear evidence of a long-term (10 years) benefit of complete revascularization was not demonstrated, and the finding should be interpreted as inconclusive.

View source

Similar papers

Open access Sep 2026

STAGED MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY ARTERY DISEASE BASED ON CORONARY PHYSIOLOGY PARAMETERS IN NON-INFARCT-RELATED ARTERIES: ANALYSIS OF OUTCOMES ACCORDING TO MID-TERM FOLLOW-UP

Highlights The study demonstrates that in patients with uncomplicated STEMI and intermediate stenoses of non-infarct-related arteries, performing staged complete revascularization only with a hemodynamically significant fractional flow reserve (FFR) value ≤ 0.80 at 30–45 days after primary intervention is associat...

K. Ibragimova, T. Sukhinina, G. Arutyunyan et al. · 0 citations
Open access Sep 2026

One-time complete revascularization vs. staged PCI in multivessel Coronary Artery Disease during a pharmaco-invasive STEMI strategy

The optimal timing of complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD) undergoing a pharmaco-invasive strategy remains uncertain. To compare one-time complete revascularization during the index PCI with staged PCI r...

Ahmed E. Gaafar, Ahmed Basyouny, Magdy Ismail et al. · 0 citations
Review Open access Oct 2026

COMPLETE VERSUS CULPRIT-ONLY REVASCULARISATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY ARTERY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

ST-elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality worldwide. Approximately 40–65% of patients present with multivessel coronary artery disease, which is associated with poorer clinical outcomes. While primary percutaneous coronary intervention (PCI) has traditionally fo...

R. Lim, C. C. Soehartono, J. Thendean · 0 citations
Review Aug 2026

Staged Versus Immediate Complete Vessel Revascularization in Patients Presenting with ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis

INTRODUCTION In patients presenting with acute coronary syndrome (ACS) STsegment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) is the preferred modality of reperfusion. However, these patients may also have multivessel coronary artery disease (CAD) on coronary angiography, which is a...

B. J. David, A. E. Valencia, R. Castro et al. · 0 citations
Review Aug 2026

Immediate Versus Staged Complete Revascularization in Patients Presenting with Acute Myocardial Infarction and Multivessel Coronary Artery Disease: A Meta-analysis with Time-to-Event Analysis.

Current guidelines recommend complete revascularization for patients with multivessel disease (MVD) presenting with acute myocardial infarction (AMI); however, the optimal timing of complete revascularization remains debated. We aimed to compare the outcomes of immediate versus staged complete revascularization in this...

Abdelrahman Hafez, Ahmed Abdelaziz, Muhammad A. Desouky et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.